BioAge Labs GAAP EPS of -$2.24 beats by $0.08, revenue of $8.99M beats by $1.88M

* BioAge Labs press release [https://seekingalpha.com/pr/20448840-bioage-labs-reports-full-year-2025-financial-results-and-provides-business-updates-from-the] (BIOA [https://seekingalpha.com/symbol/BIOA]): FY GAAP EPS of -$2.24 beats by $0.08.
* Revenue of $8.99M beats by $1.88M.
* As of December 31, 2025, BioAge had approximately $285.1 million in cash, cash equivalents, and marketable securities. Based on our current operating plan, BioAge estimates that existing cash and cash equivalents will be sufficient to fund operations and capital expenses through 2029.

MORE ON BIOAGE LABS

* BioAge Labs: Why Getting Into The Brain Might Be A Headache For Investors [https://seekingalpha.com/article/4860568-bioage-labs-why-getting-into-the-brain-might-be-a-headache-for-investors]
* Small-Cap healthcare stocks ranked by quant ratings after earnings season [https://seekingalpha.com/news/4564308-small-cap-healthcare-stocks-ranked-by-quant-ratings-after-earnings-season]
* BioAge Labs prices upsized stock offering of $115M [https://seekingalpha.com/news/4541412-bioage-labs-prices-upsized-stock-offering-of-115m]
* Seeking Alpha’s Quant Rating on BioAge Labs [https://seekingalpha.com/symbol/BIOA/ratings/quant-ratings]
* Historical earnings data for BioAge Labs [https://seekingalpha.com/symbol/BIOA/earnings]